A patent perspective of RSK inhibitors to treat cancer (2020-present)

Expert Opinion on Therapeutic Patents · Published 2026-07-27 · DOI 10.1080/13543776.2026.2708736

Free full text

Authors (2)

Aviv Preminger, Deborah A. Lannigan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Preminger, A., Lannigan, D. (2026). A patent perspective of RSK inhibitors to treat cancer (2020-present). Expert Opinion on Therapeutic Patents. https://doi.org/10.1080/13543776.2026.2708736

Related articles